Close

Emerging Companies

The Emerging Companies Section serves the needs of small to medium size BIO member companies most of whom do not yet have major products approved and on the market. This section has its own governing body and fills one-third of the seats on the board of directors. This section operates to bring their opinion to bear on major issues affecting smaller companies, and to construct programs to enhance their development.
Staff Contact: Cartier Esham

 

John Maraganore, PhD, ECS Chair
Alnylam Pharmaceuticals, Inc

Michael Narachi, Vice Chair
Orexigen Therapeutics, Inc

Jeffrey S. Hatfield, Secretary
Vitae Pharmaceuticals, Inc

Martin Babler
Principia Biopharma

Katrine Bosley
Editas Medicine

Jeff L. Cleland, PhD
Gray Bug, Inc.

Ron Cohen, MD
Acorda Therapeutics, Inc

John F. Crowley, JD, MBA
Amicus Therapeutics, Inc

Michelle Dipp, MD, PhD
OvaScience, Inc.

Douglas A. Doerfler
MaxCyte, Inc

Deborah Dunsire, MD
FORUM Pharmaceuticals Inc

Jean-Francois Formela, MD
Atlas Venture Life Sciences Advisors

Maxine Gowen, PhD
Trevena, Inc.

Peter S. Greenleaf
Sucampo Pharmaceuticals, Inc

Paul J. Hastings
OncoMed Pharmaceuticals, Inc

James Healy, MD, PhD
Sofinnova Ventures

Russell H. Herndon
Hydra Biosciences, Inc

Perry Karsen
Celgene Corporation

Rachel K. King
GlycoMimetics, Inc

Scott Koenig, MD, PhD
MacroGenics, Inc

Jonathan Leff
Deerfield Institute

Nick Leschly
bluebird bio

Bill Lis
Portola Pharmaceuticals, Inc

David Main
Aquinox Pharmaceuticals, Inc.

Joel S. Marcus
Alexandria Real Estate Equities, Inc

Thomas P. Mathers
CoLucid Pharmaceuticals, Inc

John Mendlein, PhD
aTyr Pharma, Inc.

Steven J. Mento, PhD
Conatus Pharmaceuticals, Inc

William J. Newell
Sutro Biopharma, Inc

Christian W. Nolet
Ernst & Young, LLP

John A. Orwin
Relypsa, Inc

Carlos V. Paya, MD, PhD
Immune Design Corporation

Adelene Q. Perkins
Infinity Pharmaceuticals, Inc.

Kristine Peterson
Valeritas, Inc

Mark Pruzanski, MD
Intercept Pharmaceuticals, Inc

Michael G. Raab
Ardelyx Inc.

James Sapirstein, RPh, MBA
Contravir Pharmaceuticals

Nancy Simonian, MD
Syros Pharmaceuticals

Moncef Slaoui, PhD
GSK

David M. Stack
Pacira Pharmaceuticals, Inc.

Gil Van Bokkelen, PhD
Athersys, Inc

Harold E. Van Wart, PhD
CymaBay Therapeutics

Timothy P. Walbert
Horizon Pharma, plc

Neil K. Warma
Opexa Therapeutics

Christoph H. Westphal, MD, PhD
Verastem

Thomas G. Wiggans, MBA
Dermira, Inc.

Bradford A. Zakes, MBA
Cerevast Therapeutics, Inc